Saturday 17 October 2026
Export IRMD’s income statement to Excel — free account
iRadimed Corporation
IRMD Healthcare Medical Devices
iRadimed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $83.8 million, up 14.4% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS fell 8.89% and free cash flow grew 11.7%, each against the same quarter a year earlier. Revenue growth for five consecutive years.
88.27
1.10
−1.23%
Follow IRMD
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
54.96 | 35.95 | 34.77 | 27.92 | 61.61 | 190.00 | 27.19 | 41.46 | 306.00 | 16.47 |
Piotroski F-Score |
6 | 8 | 5 | 6 | 7 | 5 | 7 | 8 | 5 | 5 |
Altman Z-Score |
55.62 | 39.44 | 20.17 | 20.98 | 34.66 | 19.28 | 16.85 | 27.10 | 18.29 | 17.14 |
P/S ratio |
14.77 | 9.51 | 9.09 | 6.71 | 13.64 | 8.72 | 6.85 | 8.65 | 7.05 | 3.73 |
P/FCF ratio |
79.57 | 44.01 | 132.86 | 50.28 | 55.62 | 55.43 | 27.39 | 37.20 | 64.04 | 16.97 |
Altman Z″-Score (non-manufacturers) |
14.84 | 15.76 | 10.86 | 14.85 | 15.22 | 13.74 | 13.07 | 14.80 | 12.83 | 15.35 |
Beneish M-Score |
(2.55) | (2.71) | (2.28) | (1.02) | (2.57) | (3.19) | (1.50) | (2.46) | (2.77) | (1.37) |
P/Operating CF |
208.96 | 116.40 | 152.33 | 117.74 | 169.49 | 110.74 | 66.80 | 74.29 | 116.18 | 54.49 |
Dividend Safety Score |
40 | — | — | — | — | — | — | — | — | — |
P/B ratio |
13.08 | 8.03 | 8.34 | 4.86 | 7.90 | 4.50 | 4.75 | 6.27 | 4.94 | 3.80 |
Price to Tangible BV |
13.57 | 8.32 | 8.65 | 5.00 | 8.03 | 4.57 | 4.83 | 6.40 | 5.08 | 3.91 |
EV/Sales |
14.16 | 8.80 | 8.33 | 5.63 | 12.15 | 7.08 | 5.65 | 7.52 | 5.91 | 2.94 |
EV/EBITDA |
43.44 | 28.29 | 26.26 | 18.40 | 45.26 | 385.25 | 21.99 | 32.18 | 52.60 | 8.04 |
EV/Operating CF |
47.56 | 25.16 | 40.57 | 29.86 | 45.12 | 38.58 | 21.26 | 31.02 | 39.94 | 10.15 |
EV/FCF |
76.28 | 40.71 | 121.76 | 42.14 | 49.53 | 45.01 | 22.59 | 32.34 | 53.67 | 13.38 |
Quick Ratio |
6.37 | 7.38 | 3.80 | 8.33 | 9.91 | 11.50 | 9.14 | 8.23 | 7.39 | 8.04 |
Current Ratio |
7.98 | 8.84 | 4.65 | 9.06 | 11.18 | 12.96 | 10.06 | 9.50 | 8.61 | 9.25 |
Net Debt/EBITDA |
(1.87) | (2.29) | (2.39) | (3.56) | (5.57) | (89.20) | (4.68) | (4.84) | (10.16) | (2.16) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.81 | 0.77 | 0.74 | 0.63 | 0.54 | 0.46 | 0.67 | 0.70 | 0.61 | 0.90 |
Operating CF/Net income |
1.11 | 1.33 | 0.78 | 0.78 | 1.21 | 4.25 | 1.06 | 1.17 | 6.83 | 1.30 |
Capex/Depreciation |
(7.22) | (10.78) | (10.46) | (2.80) | (0.53) | (0.48) | (0.39) | (0.24) | (0.63) | (1.59) |
| 24.78% | 24.31% | 23.70% | 17.59% | 13.96% | 2.34% | 19.76% | 16.84% | 1.54% | 22.61% | |
| 21.71% | 20.20% | 19.35% | 15.24% | 12.12% | 1.99% | 16.72% | 14.42% | 1.31% | 19.92% | |
ROIC |
37.60% | 39.69% | 57.82% | 62.16% | 63.44% | (5.02%) | 58.28% | 49.58% | 12.19% | 109.91% |
Return on Tangible Assets |
23.69% | 23.02% | 24.93% | 17.98% | 13.04% | 2.25% | 17.46% | 15.11% | 1.52% | 22.79% |
Average Days of Receivables |
59.52 | 52.61 | 68.06 | 90.90 | 44.84 | 52.65 | 69.11 | 50.48 | 59.76 | 42.41 |
Research and Development Expense of Revenue |
3.55% | 3.87% | 4.36% | 4.27% | 4.56% | 6.00% | 3.72% | 4.98% | 7.46% | 4.15% |
Selling, General and Administrative Expense of Revenue |
42.00% | 43.08% | 41.59% | 43.86% | 48.61% | 70.71% | 50.94% | 51.60% | 62.84% | 43.31% |
Intangible Assets out of Total Assets |
0.03 | 0.03 | 0.03 | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 |
Share Based Compensation of Revenue |
3.48% | 3.45% | 3.34% | 2.62% | 3.49% | 12.49% | 4.82% | 5.80% | 10.63% | 5.67% |
Graham Net Nets |
0.05 | 0.09 | 0.09 | 0.18 | 0.11 | 0.20 | 0.18 | 0.14 | 0.18 | 0.24 |
Graham Number |
17.21 | 15.36 | 13.17 | 11.60 | 9.93 | 3.70 | 9.76 | 7.19 | 1.87 | 6.72 |
Earnings Yield |
1.82% | 2.78% | 2.88% | 3.58% | 1.62% | 0.53% | 3.68% | 2.41% | 0.33% | 6.07% |
Free Cash Flow Yield |
1.26% | 2.27% | 0.75% | 1.99% | 1.80% | 1.80% | 3.65% | 2.69% | 1.56% | 5.89% |
Revenue per Share |
6.59 | 5.78 | 5.20 | 4.24 | 3.39 | 2.62 | 3.41 | 2.83 | 2.17 | 3.00 |
Operating CF per Share |
1.96 | 2.02 | 1.07 | 0.80 | 0.91 | 0.48 | 0.91 | 0.69 | 0.32 | 0.87 |
Capex per Share |
(0.66) | (0.70) | (0.64) | (0.15) | (0.06) | (0.05) | (0.04) | (0.02) | (0.08) | (0.14) |
Free Cash Flow per Share |
1.30 | 1.33 | 0.43 | 0.65 | 0.85 | 0.43 | 0.86 | 0.66 | 0.24 | 0.73 |
Cash per Share |
4.02 | 4.12 | 3.95 | 4.61 | 5.06 | 4.29 | 4.10 | 3.20 | 2.48 | 2.37 |
Shareholders Equity per Share |
7.44 | 6.85 | 5.67 | 5.86 | 5.85 | 5.06 | 4.92 | 3.90 | 3.10 | 2.95 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
7.44 | 6.85 | 5.67 | 5.86 | 5.85 | 5.06 | 4.92 | 3.90 | 3.10 | 2.95 |
Free Cash Flow |
16.53 | 16.81 | 5.46 | 8.17 | 10.52 | 5.18 | 9.75 | 7.11 | 2.59 | 7.88 |
Working Capital |
71.02 | 66.73 | 59.67 | 68.94 | 69.42 | 58.82 | 53.10 | 39.85 | 31.03 | 30.19 |
Capital Expenditures |
(8.42) | (8.82) | (8.01) | (1.87) | (0.74) | (0.64) | (0.49) | (0.26) | (0.82) | (1.52) |
Net Current Asset Value |
67.05 | 63.74 | 55.27 | 65.65 | 65.54 | 54.05 | 47.76 | 38.05 | 29.03 | 28.55 |
EV/EBIT |
45.38 | 29.35 | 27.26 | 19.19 | 51.74 | 0.00 | 25.16 | 38.11 | 106.17 | 8.74 |
Capex to Sales |
0.10 | 0.12 | 0.12 | 0.04 | 0.02 | 0.02 | 0.01 | 0.01 | 0.04 | 0.05 |
Price to Operating Income |
47.33 | 31.73 | 29.75 | 22.89 | 58.11 | 0.00 | 30.50 | 43.83 | 126.66 | 11.10 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.05 | 0.05 | 0.08 | 0.28 | 0.68 | 0.63 | 0.60 | 0.59 | 0.70 | 0.66 |
Cash ROIC |
11.34% | 12.09% | 4.50% | 6.20% | 7.81% | 4.57% | 9.58% | 9.32% | 4.37% | 13.69% |
Accounts Receivable Turnover |
6.92 | 6.43 | 5.14 | 5.79 | 8.61 | 5.34 | 6.70 | 7.62 | 6.11 | 8.51 |
Accounts Payable Turnover |
10.49 | 9.00 | 8.43 | 9.31 | 13.56 | 9.87 | 9.98 | 10.09 | 6.27 | 5.79 |
Inventory Turnover |
1.77 | 1.45 | 1.69 | 2.49 | 2.37 | 2.15 | 2.29 | 1.74 | 1.38 | 1.96 |
Average Days of Payables |
34.08 | 40.97 | 44.00 | 54.63 | 29.26 | 29.45 | 41.14 | 39.10 | 43.03 | 66.47 |
Days of Inventory on Hand |
217.61 | 224.77 | 303.80 | 163.03 | 160.72 | 176.34 | 150.77 | 205.46 | 275.94 | 230.49 |
Average Receivables |
12.11 | 11.39 | 12.75 | 9.21 | 4.86 | 5.93 | 5.75 | 3.99 | 3.78 | 3.82 |
Average Payables |
1.86 | 1.88 | 1.83 | 1.29 | 0.72 | 0.83 | 0.88 | 0.71 | 0.89 | 1.06 |
Average Inventory |
11.01 | 11.61 | 9.10 | 4.83 | 4.12 | 3.79 | 3.85 | 4.14 | 4.05 | 3.13 |
Average Assets |
103.55 | 95.24 | 88.83 | 84.20 | 76.97 | 68.90 | 57.59 | 43.73 | 38.10 | 36.22 |
Average Common Equity |
90.72 | 79.12 | 72.55 | 72.92 | 66.78 | 58.45 | 48.74 | 37.44 | 32.41 | 31.91 |
Columns are period end dates